By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Glaukos Corporation 

26061 Merit Circle
Suite 101
Laguna Hills  California  92653  U.S.A.
Phone: 949-367-9600 Fax:



Start Up

Company News
Study Published In Journal Of Glaucoma Evaluates A Single Glaukos iStent Trabecular Micro-Bypass Stent As A Standalone Procedure 12/12/2016 10:35:06 AM
Glaukos Announces Third Quarter 2016 Financial Results 11/11/2016 12:53:17 PM
Glaukos Completes Patient Enrollment In Initial Phase Of U.S. IDE Clinical Trial For Standalone Version Of Istent Inject 11/10/2016 2:37:55 PM
New International Study Highlights IOP-Lowering Performance Of Glaukos iStent Inject Trabecular Micro-Bypass In Standalone Procedure 11/8/2016 10:35:49 AM
Glaukos Release: iStent Trabecular Micro-Bypass Stent Reduced IOP And Medication Use In Predominately Hispanic Glaucoma Patient Population, According To Published Study 10/31/2016 11:40:21 AM
Glaukos To Release Third Quarter 2016 Financial Results After Market Close On November 10 10/13/2016 11:52:25 AM
Glaukos Featured In Various Presentations At 2016 American Academy of Ophthalmology Conference 10/6/2016 10:06:49 AM
Glaukos Release: New Study Underscores Ability Of Istent Trabecular Micro-Bypass Stent To Achieve Sustained Reductions In IOP And Medication Use In Glaucoma Patients Undergoing Cataract Surgery 9/27/2016 11:00:13 AM
International Study Shows Favorable 3-Year Results Of 2 Glaukos Istent Trabecular Micro-Bypass Stents As Initial Treatment For Naïve Glaucoma 9/23/2016 9:59:32 AM
Glaukos Announces Participation In Baird Healthcare Conference 8/25/2016 11:08:17 AM